Summit Therapeutics Inc.
SMMT
$18.22
-$0.69-3.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 238.55M | 297.87M | 361.32M | 412.35M | 486.90M |
| Total Receivables | -- | -- | -- | 557.00K | 660.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.59M | 11.05M | 9.12M | 10.52M | 2.41M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 321.00K | 319.00K | 318.00K | 325.00K | 323.00K |
| Total Current Assets | 246.47M | 309.24M | 370.75M | 423.75M | 490.29M |
|
|
|||||
| Total Current Assets | 246.47M | 309.24M | 370.75M | 423.75M | 490.29M |
| Net Property, Plant & Equipment | 6.23M | 6.24M | 7.00M | 7.40M | 8.24M |
| Long-term Investments | 2.00M | 2.04M | 1.92M | 1.86M | 1.99M |
| Goodwill | 2.00M | 2.04M | 1.92M | 1.86M | 1.99M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.03M | 6.52M | 4.15M | 2.55M | 2.33M |
| Total Assets | 261.73M | 324.04M | 383.82M | 435.56M | 502.85M |
|
|
|||||
| Total Accounts Payable | 22.25M | 22.98M | 4.99M | 4.64M | 3.25M |
| Total Accrued Expenses | 38.01M | 32.74M | 25.58M | 31.53M | 26.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.72M | 3.12M | 3.54M | 3.77M | 28.29M |
| Total Finance Division Other Current Liabilities | 1.96M | 1.49M | 759.00K | 1.80M | 1.03M |
| Total Other Current Liabilities | 1.96M | 1.49M | 759.00K | 1.80M | 1.03M |
| Total Current Liabilities | 64.93M | 60.33M | 34.88M | 41.73M | 59.01M |
|
|
|||||
| Total Current Liabilities | 64.93M | 60.33M | 34.88M | 41.73M | 59.01M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.71M | 2.44M | 2.91M | 3.45M | 4.21M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.83M | 1.84M | 1.71M | 1.63M | 1.72M |
| Total Liabilities | 69.47M | 64.60M | 39.49M | 46.81M | 64.93M |
|
|
|||||
| Common Stock & APIC | 2.27B | 2.11B | 1.62B | 1.61B | 1.59B |
| Retained Earnings | -2.07B | -1.84B | -1.28B | -1.21B | -1.15B |
| Treasury Stock & Other | -2.71M | -2.75M | -2.56M | -2.29M | -2.31M |
| Total Common Equity | 192.26M | 259.44M | 344.33M | 388.75M | 437.92M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 192.26M | 259.44M | 344.33M | 388.75M | 437.92M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 192.26M | 259.44M | 344.33M | 388.75M | 437.92M |
|
|
|||||